Polycystic ovary syndrome in Latin American populations: What is known and what remains unresolved

被引:4
作者
Abruzzese, Giselle Adriana [1 ]
Velazquez, Mariela Edith [1 ]
Cerrone, Gloria Edith [2 ,3 ]
Motta, Alicia Beatriz [1 ]
机构
[1] Univ Buenos Aires, Fac Med, Ctr Estudios Farmacol & Bot, Consejo Nacl Invest Cient & Tecn,Lab Fisio Patol O, Buenos Aires, Argentina
[2] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol Biotecnol & Genet, Buenos Aires, Argentina
[3] Univ Buenos Aires, Lab Diabet & Metab, CONICET, Inst Inmunol,Genet & Metab, Buenos Aires, Argentina
关键词
Polycystic ovary syndrome; Environmental factors; Socioeconomical factors; Metabolic alterations; Reproductive alterations; Latin; -America; Latinas; Hispanic; GENOME-WIDE ASSOCIATION; ANTI-MULLERIAN HORMONE; INSULIN-RESISTANCE; ETHNIC-DIFFERENCES; NUTRITION TRANSITION; METABOLIC SYNDROME; MEXICAN-AMERICAN; CARDIOVASCULAR RISK; CAPN10; UCSNP-43; GENE VARIANTS;
D O I
10.1016/j.jsbmb.2022.106195
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polycystic ovary syndrome (PCOS) is one of the main endocrine and reproductive disorders affecting women in their reproductive age. The syndrome is considered a multifactorial pathology. Therefore, genetic susceptibility and environmental factors contribute to PCOS development and phenotypic manifestation. Ethnicity and so-cioeconomic factors influence the development of PCOS and could affect the possibility of its diagnosis. Latin America is a unique case of study because of the heterogeneity within the region, complex socioeconomic status, and the mixed ancestry found in these populations. Up-to-date, most studies have focused on developed coun-tries' populations, and there is a lack of evidence regarding Latin-American countries. We propose to review the state of the art of PCOS knowledge regarding Latin American populations, including the metabolic and repro-ductive aspects of the syndrome and the different influencing factors, and suggest future directions to deepen the study of PCOS.
引用
收藏
页数:15
相关论文
共 153 条
  • [1] Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
    Abbott, DH
    Barnett, DK
    Bruns, CM
    Dumesic, DA
    [J]. HUMAN REPRODUCTION UPDATE, 2005, 11 (04) : 357 - 374
  • [2] Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome
    Abruzzese, Giselle A.
    Gamez, Juan
    Belli, Susana H.
    Levalle, Oscar A.
    Mormandi, Eduardo
    Otero, Patricia
    Graffigna, Mabel N.
    Cerrone, Gloria E.
    Motta, Alicia B.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (12) : 1057 - 1061
  • [3] Maternal polycystic ovary syndrome and the potential risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in the offspring: a systematic review and meta-analysis
    Abu-Zaid, Ahmed
    Bhagavathula, Akshaya Srikanth
    Rahmani, Jamal
    Alyoubi, Reem Abdullah
    Alomar, Osama
    Baradwan, Saeed
    Alkhamis, Waleed H.
    Khalifa, Mahir
    Alshahrani, Majed Saeed
    Khadawardi, Khalid
    Salem, Hany
    A. Al-Badawi, Ismail
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2022, 27 (03) : 253 - 260
  • [4] Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records
    Actkins, Ky'Era, V
    Singh, Kritika
    Hucks, Donald
    Edwards, Digna R. Velez
    Aldrich, Melinda
    Cha, Jeeyeon
    Wellons, Melissa
    Davis, Lea K.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01) : 153 - 167
  • [5] The Relationship between Clinico-biochemical Characteristics and Psychiatric Distress in Young Women with Polycystic Ovary Syndrome
    Adali, E.
    Yildizhan, R.
    Kurdoglu, M.
    Kolusari, A.
    Edirne, T.
    Sahin, H. G.
    Yildizhan, B.
    Kamaci, M.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (06) : 1188 - 1196
  • [6] Albala C, 1997, REV MED CHILE, V125, P719
  • [7] [Anonymous], 1992, POLYCYSTIC OVARY SYN
  • [8] Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis
    Arentz, Susan
    Smith, Caroline A.
    Abbott, Jason
    Bensoussan, Alan
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 17
  • [9] Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study
    Artini, P. G.
    Di Berardino, O. M.
    Papini, F.
    Genazzani, A. D.
    Simi, G.
    Ruggiero, M.
    Cela, V.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (04) : 375 - 379
  • [10] Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
    Azziz, Ricardo
    Carmina, Enrico
    Dewailly, Didier
    Diamanti-Kandarakis, Evanthia
    Escobar-Morreale, Hector F.
    Futterweit, Walter
    Janssen, Onno E.
    Legro, Richard S.
    Norman, Robert J.
    Taylor, Ann E.
    Witchel, Selma F.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) : 4237 - 4245